Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ring Closing Metathesis (RCM). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113754666A details a safe, high-yield synthesis of benzopyrazine compounds using Ring-Closing Metathesis, offering reliable API intermediate supply chains.
Patent CN1774421A reveals a novel RCM-based route for Atorvastatin intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN119039223B reveals a high-yield route for nitrogen-containing heteroaromatic derivatives. Discover cost reduction in API manufacturing and scalable supply solutions.
Patent CN107129462B details a novel total synthesis of Rupestine G via RCM. We offer scalable manufacturing, cost reduction, and high-purity pharmaceutical intermediates.